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ABSTRACT
CFD ANALYSIS OF BLOOD FLOW AND DRUG CONCENTRATION DISTRIBUTION
IN TUMOR-AFFECTED CEREBRAL ARTERY TISSUE REGION
Sindhuja Moda, MS
Department of Mechanical Engineering
Northern Illinois University, 2016
Pradip Majumdar, Director

Brain tumors occur in the brain with the growth of abnormal cells. Despite the
advancements in medical technologies and treatments, the complex geometry of the brain impedes
the treatment of tumors in the brain. A promising and efficient drug targeting to the diseased
regions with limited dosage input reduces the risk of potential damage of healthy tissue cells in the
vicinity of tumor. Insertion of drug particles into the bloodstream through intravenous
administration is one of the efficient treatment methods which is gaining importance. Currently,
extensive research is being conducted in the areas of treating brain tumors effectively with direct
administration of drug through blood. In this study a three-dimensional computational simulation
model of the artery-capillary network with cerebral part is developed and reconstructed using
multiple CT and MRI scan images of a tumor-affected patient. The simulation model includes
solution of governing equations of blood flow dynamics based on Navier-Stokes equations and
mass species transport based on Lagrangian particle flow dynamics in the artery network and
capillaries of the adjacent tissue-tumor regions subjected to typical cardiac cycle. Computational
analysis is performed to evaluate and analyze the blood flow and drug particle distributions around
the targeted region with varying concentrations. The main objective of this study is to evaluate and
optimize the effectiveness of the drug delivery to the internal targeted tumor region for different
input drug parameters such as drug type, density and dose concentrations.
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1. INTRODUCTION
1.1 Motivation
Nowadays improved medical technologies are available for efficient treatment for many
dreadful diseases, including cancer. However, despite the efficient treatments, brain tumors are
one of the leading cause of mortality. According to the statistical estimation of National Brain
Tumor Society, the average mortality rate of adult malignant brain tumors is 3.3%. Brain tumors
can originate with the growth of tumor cells within the brain or by tumor cells migrated from
another part as a secondary tumor. Brain tumors come under a special category of cancers as the
brain’s blood-brain barrier offers resistance to the intake of external agents given as drugs to treat
cancer in the brain.
Currently, extensive research is being conducted in the areas of treating brain tumors
effectively crossing the barriers of the blood-brain barrier with direct administration of drugs
through blood. However, administration of drug is to be in safe limits of dosage. Excess dosage
given in an attempt to target the tumor reaching through blood-brain barrier may harm the healthy
cells around the targeted area of the body. This study is on the development of a three- dimensional
simulation analysis model of tumor-affected brain with a blood-supplying artery integrated to it
and analyzing the drug particle movements with various parameters such as dosage, particle size,
and estimate of the safe level of drug administration to treat the target area successfully.
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Brain tumors occur in the brain with the growth of abnormal cells. Despite the
advancements in medical technologies and treatments, the complex geometry of the brain
impedes the treatment of tumors in brain. A promising and efficient drug targeting to the
diseased regions with the limited dosage inputs is essential to reduce the risk of potential damage
of healthy cells and tissues in the vicinity of tumor. Insertion of drug particles into the
bloodstream through intravenous administration is one of the treatment methods available in
treating tumor cells. In this method the tumor cells are directly targeted by the drug particles
which flow with the blood. Typical dosages of drugs are administered to the patients depending
on the extent of spread of tumor. Constant research is being carried out in improving the drug’s
targeting efficiency by changing parameters such as dosage increments and particle dimensions
depending on the severity.
1.2 Literature Review
Jhunjhunwala et al. [1] studied analysis of pulsatile blood flow in healthy and
atherosclerosis-affected artery. The study is carried out with changes in flow field. They
compared both steady and transient flow of blood and the results showed that transient flow
gives accurate results of analysis to the steady-state case. This study helped me in my work in
setting the velocity inlet boundary condition for accurate results and also for reference in
analyzing the results of the blood flow for given cardiac flow with varied velocities with respect
to time.
Khaled and Vafai [2] mainly explain and derive various models available for setting
porous medium for biological tissues. Using mass diffusion and different convective models,
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transport in porous media is reviewed. Their study shows the applications of several models and
suitability of flow models for various flow types. This study is useful to find the suitable flow
model for the different regions of the human body. Using the list of suitability mentioned in this
study, the Brinkman’s model is considered for my case as it is the best fit of all the models for
the tissues nearer to the capillaries as explained by their study.
Takami Yamaguchi et al. [3] studied fluid flow analysis on micro-scale and macro-scale
hemodynamics. Their study includes analysis on arteries and capillaries using numerical
methods. This paper mainly discussed the advantages and disadvantages of several methods
such as bending element method and volume of method. This study is helpful in analyzing the
flow in minor blood flow in minute vessels like capillaries.
Fuat Yilmaz and Gundogdu [4] have shown viewpoints on analysis of blood viscosity
model and physiological flow conditions using experimental viscosity data. The set of
experimental values of cardiac input is considered and the model is analyzed for pressure and
velocities of blood flow making changes to viscosity models. They have explained that Carreau
Yasuda model is appropriate for non-Newtonian flow of blood. For my work this paper is used
as a basic guide to define accurate viscosity model for the given condition to avoid errors.
Arifin et al. [5] in their study explained the distribution of the drug in the brain tumor
coupled to its physio-chemical properties. Their study includes design of a realistic threedimensional tissue geometry extracted from MRI images of a brain tumor for analysis as a
primary step and analyze the flow of blood in tumor considering the diffusion, reaction and
convection models in which Darcy's law is used to account for the convective contribution of
the interstitial fluid. This study is useful for analyzing the blood flow in realistic brain using

4

Darcy model.
Bello and Carroll [6] studied and evaluated the efficiency of combined chemotherapy
drugs in treating the targeted area of human gliomas. But their study was initially limited to mice.
They used carboplatin and etoposide as the two chemotherapeutic drugs. However their attempt
caused several severe side effects with a decrease in tumor volume as an only added advantage
of the study. This study has been used for my work in finding out the best drug for treating
tumors.
Shafiullah [7] in his study analyzed the blood flow dynamics of three-dimensional straight
artery with a branched structure with and without stenosis. A cardiac cycle for pressure
waveform was derived from experimental data in the simulation analysis to evaluate the stented
arteries. This study was helpful in setting up the physics of the present study and also used as a
guide for analyzing the blood flow in unsteady case.
Narmada [8], in her study extended the Shafiullah’s model of branched straight artery to
a more realistic artery network derived from the CT scan of atherosclerosis patient. She also
extended the model to include a porous medium based on Darcy’s flow dynamics model for
blood flow through artery network including a tissue region. This work is used in this study for
setting up the porous media formulation for blood transport through tissue-tumor region.
1.3 Objective
The main objective of this study is to evaluate and optimize the effectiveness of the drug
delivery to the internal targeted tumor region for different input drug parameters such as drug
type, density and dose concentrations. The objective is to design the realistic three-dimensional
artery network connected to a tumored tissue of the cerebral system and to analyze the blood
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flow and drug concentration distribution in the artery- capillary cerebral network. For this study,
the artery-capillary network with cerebral part is modeled and reconstructed using multiple CT
and MRI scan images of a tumor-affected patient. The simulation model includes solution of
governing equations of blood flow dynamics based on Navier-Stokes equations and mass species
transport based on Lagrangian particle flow dynamics in the artery network and capillaries of
the adjacent tissue-tumor regions subjected to typical cardiac cycle.
A computational analysis is performed to evaluate and analyze the blood flow and drug
particle distributions around the targeted region. In this study the particle administration is
assumed to be done directly through intravenal method and the administration is analyzed with
varying concentrations and particle diameter to identify the possibilities of treating the targeted
region effectively with prescribed safe level of dosage causing no harm to healthy cells around
the target. The main objective of this study is to evaluate and optimize the effectiveness of the
drug delivery to the internal targeted tumor region for different input drug parameters such as
drug type, density and dose concentrations.

2. BLOOD FLOW IN BRAIN AND BRAIN TUMORS
In this chapter, brief description of the human body circulatory system, characteristics of the
blood flow dynamics in artery-capillary network, cerebral network and details of brain tumor
and its treatment methods are given.
2.1 Circulatory System
Human circulatory system consists of heart which acts as pump and the blood vessels
which carry blood to and from the heart in respective cycles. This cardiovascular system’s structure
is designed to provide the body with oxygen, nutrients and also to remove waste from tissue cells.
Figure 2.1 gives the basic idea of the circulatory system.

Figure 2.1 Circulatory system
(Source: https://www.pinterest.com/pin/385761524304847833/)

7

As shown in the Figure 2.1, blood flows into the heart through veins and flows away from
the heart through arteries. However, flow of blood to various organs is worth noticing as it
involves series of changes in flow diameter from start point to the target. The oxygenated blood
carried by arteries is taken from the aorta, which is the biggest direct vessel connected to heart.
From arteries, blood flows into smaller vessels called arterioles, which divide into even smaller
vessels called capillaries [9]. The exchange of energies takes place from capillaries to the cells
and deoxygenated blood merges into venules and then into larger veins.

2.2 Cardiac Cycle
Cardiac cycle explains the pumping mechanism of heart. Each cardiac cycle consists of a
diastole and a systole phase. Blood leaves heart during systole with increased pressure in atria,
whereas during the diastolic phase the ventricles relax leaving the pulmonary and aortic valves
closed resulting in letting blood to the heart. The mitral, tricuspid, aortic and pulmonary valves
of the heart, connected to arteries leaving the heart and the lower ventricles ventricle
respectively, open and close in response according to pressure changes [9].
2.3 Blood
Blood is the fluid which flows through entire human body and provides necessary nutrients
and energy to the tissues. It contains red blood cells, white blood cells and platelets in plasma.
Blood flow exhibits non-Newtonian nature as it does not possess a constant viscosity at all flow
rates. This nature of blood makes it one of the most experimented fluid in bio-engineering field.
The other property of blood which is almost equally used in experimental applications is its
constant mass density value, which is 1050kg/cm3 [7, 8].
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2.4 Blood Vessels
Blood vessels spread all over the body, originating from the heart to supply and draw blood
from different body parts. The size of the vessels varies with the amount of the blood carried by
them. There are three major types of blood vessels. The unique characteristics of each type of
blood vessel is shown in Figure 2.2 below [7, 8].
2.4.1 Arteries and Arterioles
Arteries carry oxygenated blood from heart to all the body parts. The movement of blood
exerts high pressure on arteries as most of the force is exerted by the blood while leaving the
heart. To withstand this high pressure, artery walls are more elastic, thicker and muscular than
all other vessel walls of the circulatory system. The high elasticity of arteries allows them to
stretch and withstand higher pressures. Muscular nature offers smoothness to the arteries which
allows them to expand and contract accordingly, resulting in regulating the blood flow [7, 8].
Similar to arteries, arterioles carry blood rich in oxygen to body parts. These are the
subdivisions of arteries and are narrower than the arteries. They are thinner in size as they face
less pressures than the arteries. However they are muscular in nature like the parent vessel
(artery) and thus efficiently regulate the blood flow through a series of expansions and
contractions whenever required [7, 8].
2.4.2 Capillaries
These are the smallest of all the blood vessels in the body and connect to all the various
organs of the entire body. They have the thinnest structure with only a thin permeable layer called
endothelium, which acts as the barrier between the tissues and the blood in capillaries. The
permeability of the layer allows the blood to exchange the nutrients and oxygen as energy to the

9

tissues. Also the waste gases are in turn taken out from the tissue and carried away by the blood
through this layer in capillaries. The exhaust derived from the tissues is carried to venules from
capillaries [7, 8].The Figure 2.2 gives an idea of the blood flow.

Figure 2.2 Capillary and artery-arteriole network
(Source: https://en.wikipedia.org/wiki/Capillary
http://www.medicalexhibits.com/medical_exhibits_image.php?exhibit=09079-36)
2.4.3 Veins and Venules
Deoxygenated blood from the capillaries is to be carried back to heart for repetition of
cycle. This is done by veins in our circulatory system. Veins are thinner and less elastic in nature
compared to arteries as they are under less pressures throughout the cycle. The underlying
mechanism in pushing the blood back to the heart depends on the inertia, gravity and the muscle
contraction force. This contraction force helps in forcing blood to the heart. Venules function
similar to arteriole, but they collect and supply the deoxygenated blood back to the heart instead
of supplying blood from the heart like arterioles [8].
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2.5 Tissues
Tissues of the human body are made of series of discontinuous functional units connected
together. Many capillaries combine and form the tissue. The outermost layer of tissues is made
of muscles which are in turn made of blood vessels, capillaries and connective tissue [8].
2.6 Brain and Blood Flow
2.6.1 Brain
It is the most complex and heaviest organ of the human body responsible for the control
over the action of the entire system. It weighs around three pounds and requires 746 ml of blood
flow for every minute. Brain and spinal cord together constitute the central nervous system and
function primarily as a unit that receives signals as inputs in the form of physical and chemical
entities and interprets the information to control the body’s response. Brain is also responsible
for monitoring blood pressure and hormonal balances in the body. It has several parts with
unique functionalities in controlling the bodily actions [10]. Table 1 gives the basic details on
parts of brain and its functions.
Table 1: Parts of Brain and Their Functions

Cerebrum

Largest portion of brain

Controls physical reactions, behavior,
mental ability

Cerebellum

Little brain

Controls Posture, structure and coordination of the body

Brain Stem

Mid-brain

Regulates body movement, vision and
hearing

Medulla

Essential part of brain stem

Maintains heart rate and breathing
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In this study CT scan image of basilar artery-capillary network is considered. So the study
is basically the analysis of blood flow in tumored regions of posterior cerebrum.
2.6.2 Cerebral Blood Flow
Coronary artery arising from the heart divides into several branches to supply the blood in
neck, throat and brain regions. The blood supply to the brain is carried by the two pair of arteries
called internal carotid and basilar artery. These arteries originate from internal carotid artery and
vertebral artery which branches from the coronary artery and subclavian artery of heart. These
major arteries again branch into anterior, middle and posterior cerebral arteries to supply blood
to various parts of the brain. The anterior cerebral artery supplies blood to the middle and front
portions of brain and posterior cerebral artery supplies blood to brain stem and back portion of
brain.
The Figures 2.3 and 2.4 show and explain various parts of brain and the path of blood flow.

Figure 2.3 Path of blood flow to brain
(Source: Image snipped from a YouTube video)
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Figure 2.4 Cerebral Flow origin and flow chart of blood flow in cerebral arteries
2.7 Brain Tumors
Growth of abnormal cells in the tissues and other parts of brain leads to brain tumor. These
tumors may originate within the brain or developed due to the transfer of tumor cells from another
part of the body. These developed tissues avoid flow of blood and nutrients to the essential parts
of brain resulting in functional abnormalities [10].
Brain tumors are classified based on the following:


Origin of tumor: Tumor’s origin is the deciding factor to categorize them as primary or
secondary tumors. Primary tumors originate within the brain, whereas the secondary tumors
are derivatives of body tumors that finally reach the brain.



The part of the brain being affected: Tumor types are decided depending on the type or part
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of the organ where it arises. Brain can be affected with tumor in its tissues, brain stem and
some other tiny parts within the brain. However, brain tumors which originate in the tissues
are most common and are responsible for many deaths.
In this study tumor originated in the tissue of the brain connected to basilar artery is
considered. The CT scan images considered in designing the model for analysis are shown below
in Figures 2.5 and 2.6.
Figure 2.6 is of MRI scan image of a woman suffering from grade III astrocytoma. Astrocytoma
arises from the cells called astrocytes which are the network of glial cells. The above scans show
the area of existence of tumor and its extent of spread. From the scans both sagittal and axial, it is
evident that the woman has an abnormal mass spreading from left to right [11]. Also the intensity
of signals is shown predominantly in the right parietal lobe with an extension to corpus callosum.
Series of Axial Non-Enhanced and Contrast-Enhanced T1-Weighted, Proton Density–
Weighted, and Fluid-Attenuated Inversion Recovery MRI:

(Source: http://emedicine.medscape.com/article/336695-overview, Fig 8)
Figure 2.5 MRI scan of diseased patient
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Sagittal Non-Enhanced and Contrast-Enhanced T1-Weighted MRIs, Axial Diffusion-Weighted
Images, and Axial Apparent Diffusion Coefficient Map:

Figure 2.6 MRI scan of diseased patient
2.8 Treatment Methods
Several treatment methods are available for treating brain tumors; however, these methods
depend on factors such as type, location and size of the tumor [10]. The following are the
treatment options available:


Steroids: These are the hormones given in fixed dosages for a fixed period of time to reduce
the growth of tumors. Steroids cannot cure the tumor permanently, but they promote the
growth inhibition.



Surgery: It is the traditional treatment done as an initial attempt to remove abnormal mass from
the brain. Surgery such as biopsy, partial removal or debulking is beneficial in treating
tumors which are huge and hard to control. However risks include infections, blood clots
and more recovery time.



Chemotherapy: This process involves delivery of anti-cancer drugs travelling through the
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bloodstream to reduce the tumor growth. This procedure offers promising results without the
necessity of surgery with some potential risks like any other treatments.


Radiation Therapy: This therapy involves treatment using external beam radiation to kill the
cancer cells. This treatment is used to the parts of brain where surgery is not possible to
perform. Unlike surgery it offers chance of avoiding seizures and infections through surgery.



Stereotactic Radiosurgery: This is the new approach which is being used now-a-days. In
this method radiation is targeted to the exact vicinity of the tumor thereby reducing the
damage to the healthy tissues surrounding the tumor. This method also offers more
flexibility and avoids surgery.
Table 2: Properties of Anti-Cancer Drugs

DRUGS

PROPERTIES
Molecular Formula: C6H6N6O2

TEMOZOLOMIDE

AVASTIN

Density:1.97gm/cm^3
Molecular Weight: 194.15g/mol
Molecular Formula: C6638H1060N1720O2108S44
Density:1.03gm/cm^3

LOMUSTINE

Molecular Weight: 149196.8162 g/mol
Molecular Formula: C9H16CIN3O2
Density: 1.35gm/cm^3
Molecular Weight: 233.6952 g/mol

CARMUSTINE

Molecular Formula: C5H9Cl2N3O2
Density:1.46gm/cm^3
Molecular Weight: 214.05 g/mol

16

2.9 Anti-Cancer Drugs for Treating Tumors
In this paper, treating of brain’s tumored tissue through injection of various concentrations
of drug into the blood flow is observed. In this procedure several common intra venal anti-cancer
drugs are used for analysis. Table 2 shows the list of drugs and general dosage levels used in
treating glioma, a tumor that develops in brain tissues [6].
2.10 Blood-Brain Barrier
Some cells in the brain are connected with tight joints between them and have some
electrical resistance. These are called endothelial cells. These cells of brain forms a barrier called
blood-brain barrier which allows substances such as water, glucose and amino acids through
diffusion while avoids entry of harmful toxins. Moreover all the capillaries which are passing in the
brain are connected and surrounded by the cells of brain tissue and forms a strong barrier to avoid
invasion of infective substances and other toxins. In this scenario even the drugs given to target
the tumors in brain are being obstructed by the blood-brain barrier. Many studies have been made
and many drugs are found and designed in the way to penetrate the brain’s protective layer.
However when compared to tumors in other regions of human body, treating brain is more
difficult due to the existence of the powerful protective mechanism. In this study the drugs
Carmustine, Temozolomide which are known for its ability of penetrating the blood-brain barrier
was used.
2.11 Human Equivalent Dosage
Clinical trials on animals are done to evaluate the safe dosage for the extent of tumor
spread in humans. The tumor cells of humans are placed and cultured in healthy animals such as
mice and guniea pigs and the drugs are administered to find the power of drugs in treating the
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tumor and also the optimum dosage that can be given to kill the tumor. The obtained dosage after
the successful trial was converted to the human dosage using human equivalent dosage. In this
study in order to convert the dosage from one of the referred papers, the following equation is
used [6, 12]:
H.E.D= 𝑨. 𝑫 ∗ ((𝑨. 𝑾)/(𝑯. 𝑾))𝟎.𝟑𝟑
where
H.E.D: Human Equivalent Dosage.
A.W: Animal Weight in KG.
H.W: Human Weight in KG.
A.D : Animal Dose in (mg/kg).
2.12 Flows in Cerebral Arteries
Flow velocity of blood in the arteries and veins mainly depends on the flow area and
therefore the circulatory system of the human body, which consists of blood flow with different
velocities at different regions. Both coronary and carotid arteries which are less in size experience
lesser flow velocities. Parameters such as Reynolds number and Womersley numbers are used to
calculate and analyze the velocities in every part of the body. For instance, less Reynolds value of
300 and Womersley parameter of 4 in the carotid arteries considered in this study explain the
presence of very low velocities in those, when compared to other major arteries [13].

3. MODELING OF FLUID FLOW AND DRUG DISTRIBUTION
In this chapter, details of geometry design, physics of the flow model, use of species
transport equations, and boundary conditions are explained.
3.1 Design of Physical Model for Flow Analysis
One of the main objectives of this study is to design a three-dimensional artery connected
to capillary and the tumor region of brain, using the CT and MRI scan images of tumor-affected
patient. As it is difficult to model the geometry of capillaries with minute dimensions using general
design software such as Creo, SolidWorks, expensive 3-D convertors and extensive design
software are essentially needed for this task. However softwares such as Mimics and 3-D Doctor
are also being extensively used in designing realistic models for research purposes today. They
offer equal level of flexibility in design of complex geometries. Currently most research is being
conducted in modeling the biomedical field geometries as the simulation analysis pathway to
innovation of many technologies [14].At the same time even some design software such as Space
Claim can also perform well in doing necessary modification in design where there is appoint of
integrating two different entities subjected to study. In this study, a realistic artery- capillary system
is designed using Space Claim software and is integrated with the tumor-affected human brain. The
human brain is also modeled to the realistic dimensions using the MRI scans of the brain tumoraffected patients using the 3- D modeling software 3D-Doctor. However due to incomplete patient
data in the form of numerous MRI slices, the design modeling software gave up the partially
modeled brain with cavity at the tumor. So, the partially modeled data is taken into the design
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software Space Claim and was reconstructed to the exact dimensions of complete brain with exact
location of tumor using the raw data given by 3D-Doctor.The idea of this reconstruction was
derived from one of the online forums on SolidWorks which explained the method of construction
of brain using the scans. Also due to the incomplete data in design from the eight slices of scans
considered in this study, some of the images at the ends of the brain were extracted from this to
round out the complete brain obtained from the 3D-Doctor software. Using the raw data the design
is developed in Space Claim software [15].
3.2 Design Procedure and Model Description

Figure 3.1 Flow chart of design
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3.2.2 Procedure for Creating Designs

Figure 3.2 Steps of design
Initially the CT scan image of a 62-year-old adult is considered to model the above shown
cerebral artery. The CT scan image shows several capillaries leading to various connections in the
brain. However, for the simplicity of the design the partial part of the image is taken for modeling.
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As the part of design process, the image is inserted into the design window and splines are carried
out with respect to the image curvature. Then the splines are connected to a completed 2-D planar
image. The design software Space Claim used for this construction has the unique feature of
prompting the three-dimensional plane to the complex curvature. Using the three-dimensional
plane and the sweep options, the 3-D model is prepared as shown in the Figure 3.3.

Figure 3.3 CAD design model constructed from CT scans
Now the above-obtained model was designed by dividing the artery into three divisions
and each capillary into a separate division. The extrude option is used in joining the pieces of 3-D
parts created separately. These can be done in Space Claim easily by dragging the images without
using the assembly options. Figure 3.3 shows us the major cerebral artery of 14 mm diameter
which flows into the brain with five capillaries leading to the tissues of the brain. The most
complicated structures of capillaries which are 2mm in diameter can be seen at each outlet division.
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Each capillary attached to the tissues is approximated to a certain length for making the design
process simple. The connections at the major artery and capillary are done using the sweep extrude
option of Space Claim which prompts insertion of the capillary to the major artery following the
splines created as bounds for the extrusion. In this study the blood pumped by the heart to the
cerebral arteries is considered as the inflow and the blood flows in the major artery followed by
the smaller arteries and capillaries through the pump of heart called as systole phase.
3.2.3 Approximated Tumor in Tissue Connection
The artery-capillary unit designed in the Space Claim design module is taken into the
meshing software Hyper Mesh to do the mesh. Using the constructive options in Hyper Mesh a
circular tissue and an elliptical tumor is designed and integrated to the available threedimensional artery. The Figure 3.4 explains the design of CT scan.

Figure 3.4 3D design from CT scan
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3.2.4 Reconstructed Brain with Tumor
In order to obtain the three-dimensional model of the realistic brain from the available 3D modeling software, we need to have the slices of the patient’s complete brain which is taken as
MRI scans. MRI scans, typically in the form of number of slices, provide the accurate geometric
features of the patient complete brain. Many slices of brain in the form of MRI scans are needed to
convert the MRI scans into a complete three-dimensional brain. The number of scans needed may
vary from 80-120 depending on the accuracy of the model which has to be derived from the input
scans. However due to difficulty in finding the specific patient’s personal data through the online
resources, in this study only eight slices of the MRI scans of a specific patient are considered in
building up the three-dimensional model. The slices considered for this study consist of a tumor
of volume 128.9 mm^3 at the distance of 13 mm and 7.3mm from the frontal part and the right side
of the brain respectively. These slices are taken into the 3-D Doctor imaging software which
prompts us to arrange the slices in the appropriate order of the human brain. It also allows us to
copy the image repeatedly and arrange it an orderly manner. Now using the eight slices, the
copies are made and arranged in an orderly manner to obtain the image with series of clicks.
However due to the inadequate information in the form of slices, the image obtained in the imaging
software was a partial one. Then the obtained feature is modeled into the complete brain using
Space Claim features such as loft, sweep, etc. The final image obtained as the realistic brain is as
shown in Figure 3.5.
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Figure 3.5 3D design of reconstructed brain constructed from the MRI scans

Figure 3.6 3D design model of reconstructed brain from MRI scan
Now the previously designed artery is integrated into the tumor-affected brain cavity which
was left apart during its design due to inadequate data at certain central portions of the brain. Space
Claim was again used for this job and the final unit of the brain with a cerebral artery-capillary
network is shown in Figure 3.7.
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Figure 3.7 Transparent and opaque 3D design views
As an initial attempt, to the velocity and pressure variations during the blood flow to the
brain and tumor region are analyzed in the imaginary circular tissue region with an elliptical tumor.
Then the model of realistic brain shown above is used for analyzing the blood supply and drug
administration which reflects the real case scenario. Table 3 shows the dimensions assigned to the
two models considered for study.
Table 3: Physical Dimensions of the Computational Model
Parts

Initial Attempt 3D
Realistic 3-D Model with a Flow Path of
Model with an Imaginary Blood in Arteries and a Tumor Affected
tissue and tumor connection
Brain

Artery

11mm Length,5mm Dia

11mm Length,5mm Dia

Capillary

5mm Length,1.5 mm Dia

5mm Length,1.5 mm Dia

Tissue

314mm^2

3968mm^2

Tumor

120mm^2

35mm^2,128.9 mm^3
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3.3 Selected Physics for Flow Model
Blood behaves as a non-Newtonian fluid. Also the real case scenario of modeling blood
includes consideration of blood flow as two-phase flow as it contains red blood cells, white blood
cells and corpuscles suspended in serum. However, due to the complexity in dealing with that real
case flow of blood, the model in this study is initially simplified to Newtonian and then extended
to non-Newtonian single-phase blood flow, which is further considered with drug inflow as
another discrete phase. Table 4 details the physics assigned in modeling the blood and drug flow.
Table 4: Physics Assigned to the Model
Blood Flow

Drug Flow

Newtonian with constant

Non Newtonian with varying

viscosity input, Implicit

viscosity input, Implicit Unsteady,

Unsteady, Constant density,

Constant Density, Laminar,

Laminar, Segregated Flow

Segregated Flow

N/A

Multi-phase, EulerianLagrangian Model, Injectors,
Spherical Particles, Liquid,
Density, Particle Dimensions

3.3.1 Newtonian and Non- Newtonian Fluid
Newtonian and non-Newtonian fluids are the fluids which obey and do not obey the Newton’s
law respectively. As Newton’s law says that shear stress is directly proportional to shear rate,
Newtonian fluids have the constant viscosity coefficient, whereas the other type of flow has
varying viscosity coefficients as the shear stress and shear rates are not directly proportional to
each other. Experiments on human blood vessels show the existence of Newtonian flow in large
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arteries [1]. However, smaller arteries and capillaries show non-Newtonian behavior [8].
3.3.1 Viscosity of Flow Model
Several viscosity models are used for setting properties of the material for which the flow
is calculated. However, in this study Carreau Yesuda model is used because of its known
popularity in presenting the decreased velocity with applied shear strains, called shear thinning
property. This model is suitable for non-Newtonian flow of blood in calculating the velocities at
the wall [4, 8].
𝐧−𝟏
𝟐

𝛈𝐞𝐟𝐟 (𝛄) = 𝛈∞ + (𝛈𝟎 − 𝛈∞ )(𝟏 + (𝛌𝛄)𝟐 )

where:
η0= viscosity at zero shear rate
η∞ = viscosity at infinite shear rate
= relaxation time
= power index
The values of 0.056 Pa-s, 0.004 Pa-s, 3.313 s, 0.3568 are used respectively for the above
parameters [7].
3.3.2 Setting Porous Medium
The tissues of the brain are complex and exhibit porous nature. The nutrients carried by
the blood will be delivered to the cells in the tissue in the form energy. The energy intake and
waste disposals into the cells and venules are done by perfusion through the pores. In general,
porous medium is defined as a group of closely bound particles which exhibit anti dispersible
properties in the liquid through which it flows [8]. Mathematically it is given as follows:
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𝑠=

𝐓𝐨𝐭𝐚𝐥 𝐢𝐧𝐭𝐞𝐫𝐟𝐚𝐜𝐞 𝐚𝐫𝐞𝐚
𝐓𝐨𝐭𝐚𝐥 𝐕𝐨𝐥𝐮𝐦𝐞
𝜀=

𝐕𝐨𝐢𝐝 𝐕𝐨𝐥𝐮𝐦𝐞
𝐓𝐨𝐭𝐚𝐥 𝐕𝐨𝐥𝐮𝐦𝐞

where S: Particular Surface
ε: Porosity
3.3.3 Brinkman’s Flow Model for Porosity
Various models are utilized in analyzing the porous nature of biological tissues. Darcy
model is one of the basic models used in analyzing flows in porous media. However, many other
models such as Brinkman’s and generalized Darcy models are derived by extending the Darcy
model. These models are used in many experiments on analysis of mass transfer in porous
medium and were tested for their suitability of usage in the regions of human body [2].Results
of experiments explain that Brinkman’s porosity model could offer better results in analyzing
the mass transport in arteries near tissues. Since in this study blood flow and drug distribution
in two porous systems (i.e.,) tissue and tumor, are considered, Brinkman’s model is used for
defining porosity of the system.
3.3.4 Darcy and Brinkman’s Models
According to Darcy flow model through a porous medium the drag force on the body is
proportional to the viscosity of the fluid and velocity over the body, whereas Brinkman’s model
involves dealing with an extra term, comparable to the momentum diffusion term in the NavierStokes equation [2]. The following formula shows the mathematical representation of two
models:
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̅̅̅̅̅𝛁(𝟐) 𝑼)𝑲
(𝑮 − (𝝁)
𝑼=
𝝁
where:
U=Velocity of Blood

K= Porosity Parameter

𝜇̅= Viscosity of Blood

G= Pressure Gradient

In this study, due to complexity in solving the Brinkman’s model, the modified form,
Brinkman’s Forchheimer equation, which takes care of inertial and viscous terms, is considered.
The viscous and inertial terms are calculated using the Erguns empirical formula.

−𝛁𝑷 =
where

𝑷𝒗 =

𝟏𝟓𝟎𝝁(𝟏+−ℵ)𝟐
ℵ𝟑 𝑫𝟐

and

𝝁𝑼
+ 𝜷𝝆𝑼𝟐
𝑲

𝐏𝐢 =

𝟏.𝟕𝟓𝛒(𝟏−ℵ)𝟏
ℵ 𝟑 𝐃𝟏

Here the change in pressure and variations of molecular viscosity in the above nonlinear
equation are determined experimentally, whereas the porosity of the tissue and tumor regions is
given as 0.3 and 0.2 as the white matter; tissue of brain has the porosity 0.3 [5] .Also the porous
inertial and viscous resistance are assumed as 10500 kg/m^4, 1.5E-3 kg/m^-s and 8000kg/m^4,
1.5E-5kg/m^-s [5].
3.3.4 Drug Inflow Model
Fluid flow can be represented mathematically in Eulerian and Lagrangian flow. The basic
difference these two flows is the Eulerian flow model tracks particles with respect to a fixed origin
considering the particle phase as a continuum. The equations in Eulerian are developed using
conservation equations on a control volume basis, where as in Lagrangian type of flow the particles
are considered as the dispersed phase and the particle tracking with respect to its path is done
individually. Because of this quality, Lagrangian model is a good fit for our objective of study to
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trace the overall particle dispersion pattern. In this study the Lagrangian flow model is considered
based on the objective of the study [16].
The Lagrangian equation for particle flow is given as:
(𝑑𝑼𝑷 )/𝑑𝑇=𝐹 (𝑈−𝑼𝑷 ) +𝐺 (𝝆𝑷 -ρ)/ 𝝆𝑷 +𝐹1
where
𝑈𝑃 : Particle velocity vector
𝐹1 : Additional forces
𝐹 : Inverse of relaxation time
U: Fluid velocity
The above equation is analogous to Navier-Stokes equation and shows the force balance
of the particle flow. The first term in the right hand side includes the drag force which is expected
on the particle by the fluid. Here in this study the relaxation time includes the terms drag force and
coefficient of drag which are derived from Stoke’s law as it works best for flows with minute
cross- sections. The Reynolds number is calculated for this study considering the slip velocity of
particle which is the relative velocity between fluid and particle. The obtained Reynolds number
guides us to choose the drag models for the fluid study. In this study the obtained Reynolds number
demands the use of Nauman-Schiller equation which is one of the drag models. The second term
of the equation takes care of the gravity force exerted by the fluid flow on the particle. The
additional forces in the form of viscosity changes due to porosity responsible for changes in the
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flow are also considered here. The below terms show the mathematical expressions considered in
each term of the equation:
0.687
Coefficient of drag Cd =24(1+0.15 𝑅𝐸𝑃
)/𝑅𝐸𝑃

where Reynolds number 𝑅𝐸𝑃 =ρ.v.D /μ
F=𝑑2 𝜌/(18𝜇𝑓𝑑 )
where 𝑓𝑑 = 0.5𝑐𝑑 𝑣𝑠2 𝐴𝜌
3.4 Designed Simulation Model
3.4.1 Healthy Artery
The geometry of the healthy artery is shown in Figure 3.8. The length of the artery is
11mm and the diameter is 5mm. The capillary is of length and diameter 5mm and 1.5mm
respectively. A tissue region assumed to be spherical with dimensions 320𝑚𝑚2 is also attached
to the artery-capillary network. The geometry of the healthy artery-capillary system is as shown
in the Figure 3.8.

Figure 3.8 Geometry of the healthy artery-capillary network with healthy tissue
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3.4.2 Artery-Capillary Network with an Imaginary Tumored Tissue
The geometry of the unhealthy imaginary tissue with artery-capillary network is as shown
in the Figure 3.9. A tumor in elliptical shape is considered to be present in the spherical tissue.
The dimensions of the tumor are 120mm^2.

Figure 3.9 Geometry of the model with approximated tissue-tumor connection
3.4.3 Model with Realistic Brain Tissue
The geometry of the tumored brain is as shown in Figure 3.10. It has the average
dimensions of 140 mm in length and 120 mm in width with the thickness of 110mm. Also the
average dimensions of the tumor are 7.7 mm length, 4.65mm width and 3.6 mm thick.

Figure 3.10 3D model with tumor view
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3.4 Mesh Generation for Approximated Healthy Tissue with Artery-Capillary Network
The following are the mesh models considered for mesh. For this study Surface Remesher,
Prism Layer Mesher and Trimmer are the mesh models used. The base size given is 0.03mm with
three prism layers and 25% thickness of the base size.
Unhealthy Tissue Artery-Capillary System:

Figure 3.11 Artery mesh with node values
Figure 3.11 shows mesh Generation with number of cells for unhealthy approximated
tissue artery-capillary system.

Figure 3.12 Unhealthy spherical-shaped approximated tissue with tumor
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3.5 Mesh generation for Healthy and Tumor-Affected Reconstructed Brain Tissue
with Artery Capillary Network
The mesh of the realistic brain is generated using Hyper Mesh. The base value is given as
0.01mm with three prism layers. The surface remeshing is done manually at the complex
curvatures. The generated mesh for curved healthy and tumor-affected realistic brain tissue and
artery system is shown in the Figure 3.13.The Figures 3.14(a) and 3.14(b) show the mesh and
node values of artery. Also the Table 5 shows the mesh values of the entire brain.

Figure 3.13 Mesh of Reconstructed Brain Tissue

3.14 (a) Mesh for approximated artery with the reconstructed tumor
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Figure 3.14(b) Mesh and node values of artery and tumor with reconstructed brain
tissue

Table 5: Mesh Values of Two Models
Mesh
Healthy Artery Unit with
Capillaries

No of Cells

No of Vertices

1116710

186467

733192

2934642

451485

1118647

3582540

612988

849953

627676

69162

Reconstructed Brain with
tumor

864784

683648

72535

Reconstructed Brain with
tumor
with integrated cerebral artery

1370321

5582940

812688

Approximated Artery

505537

No of faces

System with Tissues
Artery
System with Tissues and
Tumor
Reconstructed Brain tissue
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3.6 Governing Equations
Navier-Stokes equation is used for analyzing and computing the dynamics of flow.
However some assumptions are made in analysis depending on the requirement.
3.6.1 Blood flow
As in this study initially analysis is done for finding the flow velocities and pressures in
arteries carrying blood from heart to brain, both Newtonian and non-Newtonian natures of blood
were analyzed. For this the Navier-Stokes equation is considered as Newtonian incompressible
and non-Newtonian incompressible respectively.

𝝆(

𝝏𝒖
+ (𝒖. 𝛁)𝒖) = −𝛁𝒑 + 𝛍. 𝛁 𝟐 𝒖
𝝏𝒕

The above equation is the general Navier-Stokes equation for incompressible flow. This
equation remains the same for non-Newtonian flow analysis but it has to be modified for
dealing with the other case. The modified equation is as shown below:
𝝏𝒖

𝝆 ( 𝝏𝒕 + (𝒖. 𝛁)𝒖) = −𝛁𝒑 + 𝛁(𝜼(𝛁𝒖 + (𝛁𝒖)𝑻)
Here in the above equation the viscosity and shear rate vary with time.

3.7 Boundary Conditions for Model


Velocity inlet with transient velocity data input: The set of tabulated values is given
as input velocity table for inlet of artery. This velocity table is observed from the
waveform calculated by Hashimoto [17]. The changes of velocities with respect to time
are shown in the Figure 3.15 in Table 6.
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Figure: 3.15 Inlet velocity waveform
Table 6: Velocity Range with respect to Varying Velocities



Variable

Velocity range (cm/sec)

Systolic forward peak velocity (Vf)

69±19

Diastolic reverse peak velocity

-19±6

End diastolic velocity (Vd)

8±4

Time-averaged mean velocity (Vm)

1±3

Pressure outlet at all the artery outputs and venules output: The outlet boundary is

set to zero pressure conditions.


Porosity equation for tissue and tumor: The tissue is considered spherical in shape in

an initial case and then it is improved to the real-case brain tissue. In both the design models a
tumor with imaginary shape is being enclosed in the tissues. A connection from artery and the
tissue is taken care of by the capillary and the interfaces created at the connection points. These
interfaces and the tissue and porous regions are assigned with different porosities 0.3 and 0.2
respectively. The other entities such as viscosity and inertia resistance required for the regions
are tabulated in Table 7.
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Table 7: Porosity Assigned for Different Regions of Brain

Porosity Parameters

Tissue Region

Tumor Region

Porosity

0.3

0.2

Porous Inertial Resistance 10500kg/m^4,

8000kg/m^4,

Porous Viscous Resistance 1.5E-3 kg/m^-s

1.5E-5kg/m^-s.

Input for drug flow model in multiphase Lagrangian flow: To set the particle flow for analyzing
the drug concentration distribution, Lagrangian multiphase flow is considered. A separate physics
is set for analyzing the particle flow in the artery-capillary-tissue-tumor network. The flow rate is
given an inlet to the artery using Lagrangian injectors. Also particle specifications such as
diameters and shape are specified. The Table 8 shows the flow input and particle specifications
given to analyze the flow.
Table 8: Drug Particle Parameters
CONCENTRATION

PARTICLE

PARTICLE
DENSITY

DIAMETER

0.01mL

5.0MICRON

1460 Kg/M^3

0.5 MICRON

1960 Kg/M^3

0.03mL
0.05mL
0.08mL
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3.8 Unsteady Computational Parameters
Simulations are carried out considering the segregated flow solver to solve the flow
equations. The solution update in star ccm+ for the segregated model is done using the SIMPLE
solver. Here in this study the first-order discretization is used to solve this problem and results
are drawn at different time steps with the maximum physical time of 0.8sec, time step of 0.01sec
and 50 inner iterations for each time step. Also under relaxation factors of 0.7 and 0.3 are
considered for velocity and pressure respectively [7].

4. RESULTS AND DISCUSSIONS
The computational simulation model developed is used to determine the velocity and
pressure changes in the flow of blood with respect to the cardiac cycle in the brain region with
porous tissues. Further particle distribution of drug administered into the targeted tumor region
is observed in terms of velocities with which drug reaches the target. Also the various
concentrations administered are analyzed for particle velocity with changed particle size,
density, concentration distribution and optimized concentration to determine the maximum
safest drug dosage to treat tumor in brain.
4.1 Results for Blood Flow in the Artery with Approximated Tissue-Tumor Connection
Pressure Variations:
Pressure at 0.01 Sec:

Figure 4.1 (a) Pressure at 0.01 sec in healthy artery tissue region
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Figure 4.1(b) Pressure at 0.01 sec in tumored artery tissue region
The Figures 4.1(a) and 4.1(b) show the pressure distribution of healthy and tumored
regions of brain tissue connected to the artery-capillary network. Here in Figure 4.1(a) the
pressure ranges from -701.9 pa to 2583.3 pa and in Figure 4.2 (b) it ranges from -49.9 pa to 641.72
pa. In specific, the tissue region of brain faces the pressure ranging from -44.86 pa to 612.18 pa
in a healthy artery where increase in pressure range is observed in tissue region due to the presence
of tumor.
Pressure at 0.1 Sec:

Figure 4.2 (a) Pressure at 0.1 sec in healthy artery tissue region
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Figure 4.2 (b) Pressure at 0.1 sec in tumored artery tissue region

The Figures 4.2(a) and 4.2(b) show the pressure distribution of healthy and tumored
regions of brain tissue connected to the artery-capillary network. Here in Figure 4.2(a) the
pressure ranges from -985.90pa to 3180.3 pa and in Figure 4.2 (b) it ranges from -1125pa to 3605
pa. Here the tumored tissue region of brain faces the pressure ranging from -179 pa to 767pa in
which there is an increase in pressure of 24% from the previous reading shown in Figure 4.1(a)
and 4.1(b).
Pressure at 0.25 Sec:

Figure 4.3 (a) Pressure at 0.25 sec in healthy artery tissue region
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Figure 4.3 (b) Pressure at 0.25 sec in tumored artery tissue region
The Figures 4.3(a) and 4.3(b) show the pressure distribution of healthy and tumored
regions of brain tissue connected to the artery-capillary network. Here in Figure 4.3(a) the
pressure ranges from -905pa to 3620 pa and in Figure 4.2 (b) it ranges from -1243pa to 3666
pa. Here the tumored tissue region of brain faces the pressure ranging from -500 pa to 726pa
which is comparatively 34% less than the pressures at 0.1 sec.
Pressure at 0.5 Sec:

Figure 4.4 (a) Pressure at 0.5 sec in healthy artery tissue region
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Figure 4.4 (b) Pressure at 0.25 sec in tumored artery tissue region
The Figures 4.4(a) and 4.4(b) show pressure ranges from -811pa to 2707 pa and 966 pa to
2993 pa. Here the tumored tissue region of brain faces the pressure ranging from -175 pa to
615pa.
Velocity Variations:
Velocity at 0.1 Sec:

Figure 4.5 (a) Velocity at 0.1 sec in healthy artery tissue region
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Figure 4.5 (b) Velocity at 0.1 sec in tumored artery tissue region
The Figures 4.5(a) and 4.5(b) show the velocity distribution of healthy and tumored
regions of brain tissue connected to the artery-capillary network. The velocity ranges from 0 to
3.98m/sec in non-tumor case and 3.78m/sec in tumor case, with less velocity in regions of tumor
and tissue. The above figure more precisely shows the values in closer range which is fixed to
0.05m/sec to show the tumor velocity. The above figures show the obstruction created by the
tumor for the blood flow thereby reducing the velocity in the tumor tissue region.
Velocity at 0.5 Sec:

Figure 4.6 (a) Velocity at 0.5 sec in healthy artery tissue region
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Figure 4.6 (b) Velocity at 0.5 sec in tumored artery tissue region
The Figures 4.6(a) and 4.6(b) show the velocity distribution of healthy and tumored
regions of brain tissue connected to the artery-capillary network. The velocity ranges from 0 to
4.4m/sec in non-tumor case and 4m/sec in tumor case, with less velocity in regions of tumor and
tissue. The above figure more precisely shows the values in closer range which is fixed to
0.05m/sec to show the tumor velocity. The Figure 4.6(b) shows the obstruction created by tissue
for the blood flow and also changes venules with respect to the cardiac inflow as the cycle is
being completed.
The plot in Figure 4.7 shows the velocity distributions at the 0.1 time step with respect
to position. The x-axis is taken as the diameter of the artery tube and the y-axis shows the
velocity values. The non-Newtonian velocity of tumored and healthy velocity lies in between
the values of Newtonian velocity. Siebert says that Newtonian model cannot predict the
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accurate values at the regions such as large and minor arteries [18]. Even in this study the
Newtonian flow exceeded the values of porosity and boundary conditions assigned.

Figure 4.7 Velocity plots which shows comparisons of velocities with respect to diameter

Figure 4.8 Points considered to draw plots with respect to position from the reference
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Figure 4.9 (a) Velocity plots with respect to position
The plots in Figure 4.9(a) show the velocity variation with respect to position of the
artery. As we move from left to right with respect to position on x-axis as shown in Figure 4.8,
the velocity decreases in the area of capillary due to higher resistance. The values vary from 1.4
m/sec in higher arteries to 0.18 and 0.15 at lower arteries. This shows the real mechanism of
blood flow from heart to capillaries, which is generally lower to allow time for exchange of
energy to tissues. Since the values are higher for major arteries, the plots shown above include
two sets of values which shows both the flows in major arteries that are much higher than the
other set of values in regions other than capillaries. In the above plot the lines obtained with the
artery velocity is represented by the line with left-sided arrow, whereas the rest of the flow lines
are shown with right arrows.
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Figure 4.9(b) Pressure variations of blood flow with respect to position
The plot in Figure 4.9(b) shows the pressure distribution at 0.1, 0.25, 0.5 time. The
pressure reduces with the resistance to flow due to obstruction, so there is a pressure variation
in the tissue tumor region. The artery at 2mm shows the highest pressure as there is no
obstruction to the flow, whereas the capillaries and tumor-tissue region have lower pressure.
Then the outflows are shown with raised pressure due to the suction created at the heart valves
demanding the next cardiac cycle to start and repeat. The plot here is also considering the points
shown in Figure 4.8 as the points of interest to observe changes in pressures. However due to
huge changes in values between the artery and the other areas, even here the secondary axis is
taken to show the changes in the above plot. Here the dotted line with a left arrow marking
shows the pressure changes with time in the major artery and the values shown at the side of
left-handed arrow represent the respective values of major artery at different times, whereas the
right-hand side values are the values of the rest of the regions at different time.
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4.2 Results for Blood Flow in the Reconstructed Cerebral Artery-Brain-Tumor Connection
Velocity at 0.1 Sec:

Figure 4.10(a) Velocity at 0.1 Sec in frontal region of reconstructed brain

Figure 4.10(b) Velocity at 0.1 Sec in mid-section of reconstructed brain
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The Figures 4.10(a) and 4.10(b) show the velocity distribution of the frontal and midsectional tissue regions of brain. The velocity ranges from 0 to 8E-6m/sec in frontal tissue region
and 2E-9 to 3.8 m/sec in mid-plane with tumor. The case (b) velocity is scaled to see the effect
of flow in the plane of tumor. The above figures show the obstruction created by tumored tissue
causes the less blood flow in the mid-plane. However the other parts of the brain shown in case
(a) changes with higher velocity with respect to the cardiac inflow.
Velocity at 0.125 Sec:

Fig 4.11(a) Velocity at 0.125 Sec in frontal region of reconstructed brain

Fig 4.11(b) Velocity at 0.125 Sec in mid-section of reconstructed brain
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The Figures 4.11(a) and 4.11(b) show the velocity distribution of the frontal and midsectional tissue regions of brain at point 0.125 time. The velocity ranges from 0 to 1.9E- 6m/sec
in frontal tissue region and 3E-8 to 4.48m/sec in mid-plane with tumor. The case (b) velocity is
scaled to see the effect of flow in the plane of tumor. The above figures show the obstruction
created by tumored tissue causes the less blood flow in the mid-plane. However the other parts of
the brain shown in case (a) shows higher velocity than the mid-plane but 9% higher than the 0.1
time velocity. In this figure the inflow velocity being distributed from inflow to the tissue is
observed clearly.
Velocity at 0.25 Sec:

Fig 4.12(a) Velocity at 0.25 Sec in frontal region of reconstructed brain
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Fig 4.12(b) Velocity at 0.25 Sec in mid-section of reconstructed brain
The Figures 4.12(a) and 4.12(b) show the velocity distribution of the frontal and midsectional tissue regions of brain at point 0.25 time. The velocity ranges from 0 to 2.7E- 6m/sec in
frontal tissue region and 4E-9 to 1.1m/sec in mid-plane with tumor. The case (b) velocity is scaled
to see the effect of flow in the plane of tumor. The above figures show the obstruction created by
tumored tissue causes the less blood flow in the mid-plane. However the other parts of the brain
shown in case (a) show higher velocity than the mid-plane.
Velocity at 0.5 Sec:

Figure 4.13(a) Velocity at 0.5 Sec in frontal region of reconstructed brain
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Figure 4.13(b) Velocity at 0.5 Sec in mid-section of reconstructed brain
The Figures 4.13(a) and 4.13(b) show the velocity distribution of the frontal and midsectional tissue regions of brain at point 0.5time. The velocity ranges from 0 to 6.736E- 6m/sec
in frontal tissue region and 3.5E-8 to 1.237m/sec in mid-plane with tumor. The case (b) velocity
is scaled to see the effect of flow in the plane of tumor. The above figures show the obstruction
created by tumored tissue causes the less blood flow in the mid-plane. However the other parts of
the brain shown in case (a) show higher velocity than the mid-plane following the rise in cardiac
cycle.
Now the velocities are analyzed with respect to planes. A two-sectional probe at the
site of tumor and posterior parts of the brain is created to see the blood flow in both parallel
and perpendicular planes. The perpendicular plane created at a distance of 105mm from the
left of the brain at the origin of tumor is in Figure 4.14.
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Figure 4.14 (a) Velocity at perpendicular sectional plane of reconstructed brain at 0.01 sec

Figure 4.14 (b) Velocity at perpendicular sectional plane of reconstructed brain at 0.1 sec
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Figure 4.14 (c) Velocity at perpendicular sectional plane of reconstructed brain at 0.125 sec

Figure 4.14 (d) Velocity at perpendicular sectional plane of reconstructed brain at 0.25 sec
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The Figure 4.14(d) shows the blood flow velocity distribution at different time steps of
the cycle. The value at 0.1 time starts from 0.0065m/sec as the highest velocity and 0.0013m/sec
as lowest velocity. However the velocity at tumor site is even lower than 0.0013m/sec. Then
with the rise in flow through the cycle there is an increase in velocity both at tumor and tissue
regions to 0.002m/sec and 0.0056m/sec respectively shown in Figure (a) and (b). At time step
0.25, there is lower velocity due to negative rise in the velocity. Finally at the time 0.5 the
velocity rises following the cardiac cycle.
Similarly a parallel plane is created at the posterior part of the brain. As shown in the
frontal regions of brain the posterior planes also showed higher velocity when compared to the
regions of the tumored mid-plane. However when compared to the parallel and perpendicular
planes it shows different values due to differences in the distance from the capillary which
supplies blood. For this reason, parallel and perpendicular planes are not compared but the
changes are shown in this study.

Figure 4.15 (a) Velocity at rear plane of reconstructed brain tissue at 0.1 sec
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Figure 4.15 (b) Velocity at rear plane of reconstructed brain tissue at 0.125 sec

Figure 4.15 (c) Velocity at rear plane of reconstructed brain tissue at 0.25 sec
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Figure 4.15 (d) Velocity at rear plane of reconstructed brain tissue at 0.5 sec
As shown in the Figure 4.15 the velocity follows the cardiac cycle. The velocity rises from
0.1 to 0.125 time step then it decreases to 1.77E-7 and then rises to 9.7E- following the cycle.
Figure 4.16 shows the velocity distributions at three different planes cut in parallel to the brain.
The plots shows the highest velocities at both planes in the front and the back since there is no
obstruction to the flow, whereas the velocity in the plane of tumor existence showed a less velocity
of about 30% when compared to the other planes.

Figure 4.16 Velocity distributions in sections of brain
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The plot in Figure 4.16 contains two different sets of values. So a secondary axis is
chosen to show the velocity variations in the same plot. The dotted line shows velocity in
the mid-section of the brain, whereas the rest of the regions show the velocity in frontal and
rear regions of brain. The respective values of dotted and normal lines show the velocity
with the arrows towards left and right respectively.
Pressure Variations:
Pressure at 0.1 Sec:

Figure 4.17(a) Pressure at 0.1 Sec of reconstructed brain
The Figure 4.17(a) shows the pressure distribution of healthy and tumored regions of
brains tissue connected to the artery-capillary network. Here the pressure ranges from -3182.3
pa to 8127.8 pa. In specific, the tissue region of brain faces the pressure is 5865.8 pa in a healthy
artery where increase in pressure range is observed in tissue region due to the presence of tumor.
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Figure 4.17(b) Pressure at 0.125 sec of reconstructed brain
The Figure 4.17(b) shows the pressure distribution of healthy and tumored regions of
brain tissue connected to the artery-capillary network. Here the pressure ranges from -20839pa
to 1.28E5pa. Here the tumored tissue region of brain faces the pressures that are being changed
drastically with an increment by 15%.

Figure 4.17(c) Pressure at 0.25 sec of reconstructed brain
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The Figure 4.17(c) shows the pressure distribution of healthy and tumored regions of brain
tissue connected to the artery capillary-network. Here the pressure ranges from -1125.5pa to
532.21pa. Here the tumored tissue region of brain faces the negative pressure analogous to cardiac
input.

Figure 4.17(d) Pressure at 0.5 sec of reconstructed brain
The Figure 4.17(d) pressure ranges from -83pa to 674.2 pa and 88 pa to 966 pa following
the rise in cardiac input.

Figure 4.18 (a) Pressure at perpendicular sectional plane of reconstructed brain at 0.1 sec
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Figure 4.18 (b) Pressure at perpendicular sectional plane of reconstructed brain at 0.125
sec
The Figures 4.18 (a) and 4.18 (b) show the pressure distributions in the sectional planes
cut perpendicular to the brain. At time 0.1 sec the pressure is higher in the regions of brain tissue
where there is no tumor. The tumor region has lower pressure due to obstruction which causes
the pressure drop. The pressure ranges from 1412 pa in tumor region and 7060pa in non-tumor
regions, whereas at time 0.125 the pressure changes increase at the respective site by 10%.

Figure 4.18 (c) Pressure at perpendicular sectional plane of reconstructed brain at 0.25 sec
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Figure 4.18 (d) Pressure at perpendicular sectional plane of reconstructed brain at 0.5 sec
The Figure 4.18(d) shows the negative pressure following the cardiac flow. Then the
pressure rises at the time 0.5 sec by 6%.

Figure 4.19 Points considered to draw plots with respect to position from the reference
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The plot in Figure 4.20 shows the pressure distributions at a section plane cut in parallel
to the brain. The plot shows the highest pressure at the ends of the brain and lowest pressures at
the region of tumor existence due to the resistance to flow at each time. However a line probe is
plotted to see the variation at each time with respect to the position of tumor. The variations are
shown in the plot. The pressures are about 6000 pa at the initial time for both frontal and posterior
planes, whereas the pressure is 3000 pa at the same time near the tumor. Even the other time
steps following same trend can be observed from the plot.

Figure 4.20 Pressure at sectional plot with change in position
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4.3 Results for Drug Distribution in the Artery with Imaginary Tissue-Tumor Connection
For the initial case analysis, the drug Temozolomide is used with concentrations in safe range of
0.03 mL -0.08 mL using the advection diffusion principle in multiphase Lagrangian modeling of
star Ccm+. In this initial case study particle velocities of drug with concentrations of 0.03 mL,
0.05mL, and 0.08mL are observed with changed particle dimension values of 5, 0.5 microns. The
results below are obtained at times from 0.1-0.5 sec of cardiac cycle for the changed concentrations
and changed particle dimensions.
4.3 Results with Dosage
Particle Velocity at 0.1 Time with 0.03 mL Concentration:
4.3.1 0.03 mL:

Figure 4.21(a) Particle velocity at 0.1sec
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The Figure 4.21(a) shows the particle velocity at 0.1 time step when a dosage of 0.03mL
is inserted into the blood stream. The highest velocity with which the particle flows is 4m/sec.
However the tissue and the tumor regions receive blood flow with lesser velocities which is
numerically not very clearly visible in this figure.
Particle Velocity at 0.125 Time with 0.03 mL Concentration:

Figure 4.21(b) Particle velocity at 0.125sec
The Figure 4.21(b) shows the particle velocity at 0.125 time when a dosage of 0.03mL is
inserted into the blood stream. The highest velocity with which the particle flows is 4.7m/sec.
However the tissue and the tumor regions receive blood flow with lesser velocities which is
numerically not very clearly visible in this figure. Also it is the highest velocity observed with in
the cardiac cycle. We can also observe increased particle flow due to the increased cardiac input
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into the tumor tissue region compared to previous and the other flows at various time steps shown.
Particle Velocity at 0.2 Time Step with 0.03 mL Concentration:

Figure 4.21(c) Particle velocity at 0.2sec
The Figure 4.21(c) shows the particle velocity at 0.2 time when a dosage of 0.03mL is
inserted into the blood stream. Here the particle flows with a maximum velocity of 3.5m/sec.
We can also observe a downfall of particle flow due to the change in cardiac input into the
tumor tissue region compared to previous flow. However the particle concentration in the tumor
tissue region appears almost similar to the case of 0.125 time.
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Particle Velocity at 0.25 Time with 0.03 mL Concentration:

Figure 4.22(d) Particle velocity at 0.25sec
The Figure 4.22(d) shows the particle velocity at 0.25 time when a dosage of 0.03mL is
inserted into the blood stream. Here the particle flows with a maximum velocity of 3.4m/sec.
We can observe at this stage majority of particle flow is very slow in velocity in both artery
and tumor region compared to previous flow. However the particle concentration in the tumor
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tissue region appears almost similar to the case of 0.125 and 0.2 time.
Particle Velocity at 0.3 Time Step with 0.03 mL Concentration:

Figure 4.21 (e) Particle velocity at 0.3 sec
The Figure 4.21(e) shows the particle velocity at 0.3 time when a dosage of 0.03mL is
inserted into the blood stream. Here the maximum particle flow velocity even drops to 2.2m/sec
resembling the cardiac cycle. We can also observe less flow in the arterial region compared to
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the tumor tissue regions are the half cycle is completed at this stage.
Particle Velocity at 0.4 Time with 0.03 mL Concentration:

Figure 4.21(f) Particle velocity at 0.4sec
The Figure 4.21(f) shows the particle velocity at 0.4 time when a dosage of 0.03mL is
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inserted into the blood stream. The values obtained at this time step is 0.79m/sec. Also only a
few particles are observed in the artery regions as the cycle is being finished.
4.3.2. 0.05 mL:
Particle Velocity at 0.1 Time with 0.05 mL Concentration:

Figure 4.22(a) Particle velocity at 0.1sec
The Figure 4.22(a) shows the particle velocity at 0.1 time when a dosage of 0.05mL is
inserted into the blood stream. The value obtained at this time step is 3.987m/sec, which is the
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maximum value observed at the arterial flow. However the tissue and tumor regions are shown
with semi- filled particle flow with lower velocities ranging from 0 to 0.7973 m/sec. Also only
a few particles are observed in the artery regions as the cycle is being initiated.
Particle Velocity at 0.125 Time with 0.05 mL Concentration:

Figure 4.22(b) Particle velocity at 0.125sec
The Figure 4.22(b) shows the particle velocity at 0.125 time step when a dosage of
0.05mL is inserted. The highest velocity is obtained at this time step and the observed velocity
is 5.6852 m/sec. However the tissue and tumor regions are shown with completely filled particle
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flow with lower velocities ranging from 0 to 1.1370 m/sec. Also increased concentration of
particle inflow is observed at this time step.
Particle Velocity at 0.2 Time with 0.05 mL Concentration:

Figure 4.22(c) Particle velocity at 0.2sec
The Figure 4.22(c) shows the particle velocity at 0.2 time when a dosage of 0.05mL is
inserted. The highest velocity is obtained at this time step and the observed velocity is 4.41
m/sec. However the tissue and tumor regions are shown with completely filled particle flow with
lower velocities ranging from 0 to 0.8825 m/sec. Also increased concentration of particle inflow
is observed at this time.
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Particle Velocity at 0.25 Time with 0.05 mL Concentration:

Figure 4.22(d) Particle velocity at 0.25sec
The Figure 4.22(d) shows the particle velocity at time 0.25 time with a dosage of 0.05mL.
The highest observed velocity at this time is 2.8840 m/sec. However the tissue and tumor regions
are shown with completely filled particle flow with similar concentrations to the previous time.
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Particle Velocity at 0.3 Time with 0.05 mL Concentration:

Figure 4.22(e) Particle velocity at 0.3sec
The Figure 4.22(e) shows the particle velocity at time step 0.3 time with a dosage of
0.05mL. The highest observed velocity at this time step is 1.85 m/sec. However the tissue and
tumor regions are shown with completely filled particle flow and the arteries show less particle
flow.
Particle Velocity at 0.4 Time with 0.05 mL Concentration:

Figure 4.22(f) Particle velocity at 0.4sec
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The Figure 4.22(f) shows the particle velocity at time step 0.4 time with a dosage of
0.05mL. The highest observed velocity at this time is 0.33846 m/sec. Here the tissue and tumor
regions are shown with completely filled particle flow with similar concentrations to the
previous time, but there is much less particle flow in arterial region.
4.3.3 0.08 mL:
Particle Velocity at 0.1 Time with 0.08 mL Concentration:

Figure 4.23(a) Particle velocity at 0.1sec
The Figure 4.23(a) shows the particle velocity at 0.1 time when a dosage of 0.08mL is
given to blood flow through intravenous administration into the blood stream. The value
obtained at this time step is 3.987m/sec, which is the maximum value observed at the arterial
flow. Only a few particles are observed in the artery regions as the cycle is being initiated.
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Particle Velocity at 0.125 Time with 0.08 mL Concentration:

Figure 4.23(b) Particle velocity at 0.125sec

The Figure 4.23(b) shows the particle velocity at 0.125 time when a dosage of 0.08mL is
inserted. The highest velocity is obtained at this time step and the observed velocity is 5.7m/sec.
However the tissue and tumor regions are shown with completely filled particle flow with lower
velocities ranging from 0 to 1 m/sec.
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Particle Velocity at 0.2 Time with 0.08 mL Concentration:

Figure 4.23(c) Particle velocity at 0.2sec
The Figure 4.23(c) shows the particle velocity at 0.2 time when a dosage of 0.08mL is
inserted. The highest velocity is obtained at this time and the observed velocity is 4.4 m/sec.
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Particle Velocity at 0.25 Time with 0.08 mL Concentration:

Figure 4.23(d) Particle velocity at 0.25sec
The Figure 4.23(d) shows the particle velocity at time step 0.25 time with a dosage of
0.08mL. The highest observed velocity at this time step is 4.5 m/sec. However the tissue and
tumor regions are shown with completely filled particle flow with similar concentrations to
the previous time.
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Particle Velocity at 0.3 Time with 0.08 mL Concentration:

Figure 4.23 (e) Particle velocity at 0.3sec
The Figure 4.23(e) shows the particle velocity at time step 0.3 time with a dosage of
0.08mL. The highest observed velocity at this time is 1.056 m/sec. Here likewise the previous
cases the tissue and tumor regions are shown with completely filled particle flow and the arteries
show less particle flow.
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Particle Velocity at 0.4 Time with 0.08 mL Concentration:

Figure 4.23(f) Particle velocity at 0.4sec
The Figure 4.23(f) shows the particle velocity at time step 0.4 time with a dosage of
0.08mL. The highest observed velocity at this time is 0.046528 m/sec. Even here like the
previous concentration, results of the tissue and tumor regions are shown with completely filled
particle flow with similar concentrations to the previous time step, but there is much less particle
flow in arterial region.
In the above results with different concentration input, the velocity in the overall system
looks similar with the concentrations of 0.05mL and 0.08 mL. However in order to predict the
velocity and concentration at the tissue tumor region the velocities are scaled and snapped to
the regions of tissue and tumor and analyzed for better penetration velocities as shown below.
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4.4 Comparison of Velocities with Respect to Concentration in Increasing Order
0.1 Time:

Figure 4.24 (a) 0.03mL

Figure 4.24(b) 0.05mL

Figure 4.24(c) 0.08 mL
Figure 4.24 Particle velocity changes at tissue-tumor region at 0.1 time
The Figure 4.24 shows the particle velocity change at time step 0.1 time step with a change
in dosage from 0.03mL to 0.08mL. The highest observed velocity at this time is 3.9 m/sec for
0.03mL and least for 0.08mLas 3.5 m/sec. Then the velocity decreased with increase in
concentration.
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0.125 Time:

Figure 4.25(a) 0.03mL

Figure 4.25(b) 0.05mL

Figure 4.25(c) 0.08mL
Figure 4.25 Particle velocity changes at tissue-tumor region at 0.125 time
The Figure 4.25 shows the particle velocity change at time 0.125 with a change in
dosage from 0.03mL to 0.08mL. The highest observed velocity at this time is 4.7 m/sec for
0.03mL. Then the velocity decreased with increase in concentration.
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0.3 Time:

Figure 4.26 (a) 0.03mL

Figure 4.26(b) 0.05mL

Figure 4.26 (c) 0.08 mL
Figure 4.26 Particle velocity changes at tissue-tumor region at 0.3 time
The Figure 4.26 shows the particle velocity change at time step 0.3 time with a change in
dosage from 0.03mL to 0.08mL. The highest observed velocity at this time is 1.9 m/sec for
0.03mL and least for 0.08mL as 1.09 m/sec. Then the velocity decreased with increase in
concentration.
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0.4 Time:

Figure 4.27 (a) 0.03mL

Figure 4.27 (b) 0.05mL

Figure 4.27 (c) 0.08 mL
Figure 4.27 Particle velocity changes at tissue-tumor region at 0.4 time
The Figure 4.27 shows the particle velocity change at time step 0.4 time with a change in
dosage from 0.03mL to 0.08mL. The highest observed velocity at this time step is 0.79 m/sec for
0.03mL and least for 0.08mLas 0.047m/sec. Then the velocity decreased drastically with increase
in concentration and also due to the decreased blood flow through cardiac input.
Now, to analyze the velocity within the vicinity of tumor, a line probe originating from
the capillary and passing through the tumor is drawn. The following results show the velocity
changes in the tumor at the central area.
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4.5 Velocity Changes with respect to Cardiac Cycle in Tumor at the Central Area
The Figure 4.28 shows the velocity with which the particle is flowing in the tumor area
from the capillaries penetrating through the tissue.
0.125 Time:

Figure 4.28 (a) 0.03mL

Figure 4.28 (b) 0.05mL

Figure 4.28 (c) 0.08 mL
Figure 4.28 Line probe of particle velocity at tissue-tumor region at 0.125 time
The Figures 4.28 (a), (b), (c) show the particle velocity change at time 0.125 sec with a
change in dosage from 0.03mL to 0.08mL. The highest observed velocity at this time is
0.075m/sec for 0.03mL and least for 0.08mL as 0.042m/sec.
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0.3 Time:

Figure 4.29 (a) 0.03mL

Figure 4.29 (b) 0.05mL

Figure 4.29 (c) 0.08 mL
Figure 4.29 Line probe of particle velocity at tissue-tumor region at 0.3 time
The Figure 4.29 shows the particle velocity change at 0.3 time with a change in dosage
from 0.03mL to 0.08mL. The highest observed velocity at this time is 0.0023m/sec for 0.03mL
and least for 0.08mL as 0.00012m/sec.
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0.4 Time:

Figure 4.30 (a) 0.03mL

Figure 4.30(b) 0.05mL

Figure 4.30 (c) 0.08 mL
Figure 4.30 Line probe of particle velocity at tissue-tumor region at 0.4 time
The Figure 4.30 shows the particle velocity change at time step 0.4 time with a change in
dosage from 0.03mL to 0.08mL. The highest observed velocity at this time is 0.0023m/sec for
0.03mL and least for 0.08mL as 6.4E-5m/sec.
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Figure 4.31 Drug distribution with various concentration input with respect to
cardiac input
The plot in Figure 4.31 shows the velocity with which the particle penetrates into the
tissue tumor region with different input concentrations. It is observed that with increase in
concentration the particles are moving with slower velocity into the regions of tissue and tumor.
However each input is following the cardiac input cycle. This plot can only emphasize the effect
on velocity with increase in concentration. But in order to show the particles which are entering
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into the tissue region we have to see the particle count or volume fraction.
Concentration at line probe:
Velocity alone cannot assure us to find out the effect of drug in the site of tumor.
Concentration distribution analysis gives better idea. A line probe passing through the tumor is
drawn to analyze the concentration of drug particles at that site. The Figure 4.23(a) and 4.23(b)
show the distribution variation with respect to drug changes. I t is observed in plot that with
increase in dosage there is huge increment in particle settling up at the target region. But there is
less difference observed with the concentration increase from 0.05mL to 0.08mL.

Figure 4.32 (a) Probe

Figure 4.32 (b) Concentration at line probe with varying dosage level
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4.6 Results for Drug Distribution in Reconstructed Brain
For this case two drugs which can cross the protective barriers of brain are considered.
The densities of the drugs are 1460 and 1960kg/m^3 respectively. Using the human equivalent
drug dosage estimation, the dosages of 0.01mL, 0.03mL and 0.05mL are considered as
administering dosages for this study. The below results are obtained at time steps from 0.1-0.5
sec of cardiac cycle for the changed concentrations, changed particle dimensions and changed
densities.
4.6.1 Dosage of 0.01 mL:

Particle Velocity at 0.1 Time with 0.01 mL Concentration:

Figure 4.33(a) Particle velocity in reconstructed brain at 0.1 time with 0.01mL
The Figure 4.23(a) shows the particle velocity at 0.1 time when a dosage of 0.01mL
is inserted into the blood stream. The highest velocity with which the particle flows is
3.8203m/sec. However the tissue and the tumor regions receive blood flow with lesser
velocities which are numerically negative.
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Particle Velocity at 0.125 Time with 0.01 mL Concentration:

Figure 4.33(b) Particle velocity in reconstructed brain at 0.125 time with 0.01mL
The Figure 4.33(b) shows the particle velocity at 0.125 time when a dosage of 0.01mL is
inserted into the blood stream. The highest velocity with which the particle flows is
4.5230m/sec. However the tissue and the tumor regions receive blood flow with lesser
velocities. There is an increased particle flow due to the increased cardiac input into the tumor
tissue region compared to previous and the other flows at various times shown.
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Particle Velocity at 0.25 Time with 0.01 mL Concentration:

Figure 4.33(c) Particle velocity in realistic brain at 0.25 time with 0.01mL
The Figure 4.33(c) shows the scaled particle velocity at 0.25 time when a dosage of
0.01mL is inserted into the blood stream. Here the maximum particle velocity observed is
1.8m/sec.
Particle Velocity at 0.5 Time with 0.01mL Concentration:

Figure 4.33 (d) Particle velocity in reconstructed brain at 0.5 time with 0.01mL
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Figure 4.33 (e) Scaled particle velocity in reconstructed brain at 0.5 time with 0.01mL
The Figure 4.33(e) shows the particle velocity at 0.5 time when a dosage of 0.01mL is
inserted into the blood stream. The values obtained at this time is 1.17m/sec. Here only a few
particles are observed in the tissue regions and concentrated particle at the tumor region as the
cycle is being finished.
4.6.2 Dosage of 0.03 mL:
Particle Velocity at 0.1 Time with 0.03 mL Concentration:

Figure 4.34 (a) Particle velocity in reconstructed brain at 0.5 time with 0.03mL
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The Figure 4.34(a) shows the particle velocity at 0.1 time when the drug dosage of
0.03mL is inserted into the blood stream. The highest velocity with which the particle flows is
3.8425m/sec. However the tissue and the tumor regions receive blood flow with lower
velocities compared to the 0.01mL dosage. But in both cases, the values are numerically
negative.
Particle Velocity at 0.125 Time with 0.03 mL Concentration:

Figure 4.34(b) Particle velocity in reconstructed brain at 0.125 time with 0.03mL
The Figure 4.34(b) shows the particle velocity at 0.125 time when a dosage of 0.03mL is
inserted into the blood stream. The highest velocity with which the particle flows is 4.48m/sec.
This velocity is the highest peak velocity observed during the cardiac cycle at this time,
reflecting the highest drug flow. Even here the tissue and the tumor regions receive blood flow
with lesser velocities of 1.405E-9 m/sec.
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Particle Velocity at 0.25 Time with 0.03 mL Concentration:

Figure 4.34(c) Particle velocity in reconstructed brain at 0.25 time with 0.03mL
The Figure 4.34(c) shows the particle velocity at 0.25 time. Here the particle flows with
a maximum velocity of only 1.1021m/sec. The scaled magnitudes show the better view of
changes in particle velocity. In this time the particle velocity is least and it reaches the value
of 2.887E-9m/sec, which is the least velocity observed through the cycle.
Particle Velocity at 0.5 Time with 0.03mL Concentration:

Figure 4.34(d) Scaled particle velocity in reconstructed brain at 0.5 time with 0.03 mL
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The Figure 4.34(d) shows the scaled particle velocity at 0.5 time when a dosage of 0.03mL
is inserted into the blood stream. The highest velocity values obtained at this time is 1.08 m/sec
at the artery and 4.0065E-8 at the target area. Here only a few particles are observed in the tissue
regions and concentrated particle at the tumor region as the cycle is being finished. However the
particle velocity raised with respect to rise in cardiac cycle flow.

4.6.3 Dosage of 0.05 mL:
Particle Velocity at 0.1 Time with 0.05 mL Concentration

Figure 4.35(a) Particle velocity in reconstructed brain at 0.1 time with 0.05 mL
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The Figure 4.35(a) shows the particle velocity at 0.1 time when the drug dosage of 0.05mL
is inserted into the blood stream. The highest velocity with which the particle flows is 3.9m/sec.
However the tissue and the tumor regions receives blood flow with lower velocities compared to
the 0.01mL dosage, but in both cases the values are numerically negative.
Particle Velocity at 0.125 Time with 0.05 mL Concentration:

Figure 4.35(b) Particle velocity in reconstructed brain at 0.125 time with 0.05 mL
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The Figure 4.35(b) shows the particle velocity at 0.125 time when a dosage of 0.05mL is
inserted into the blood stream. The highest velocity with which the particle flows is
4.5004m/sec. This velocity is the highest peak velocity observed during the cardiac cycle at this
time, reflecting the highest drug flow. Even here the tissue and the tumor regions receive blood
flow with lesser velocities of 5.56E-10m/sec.
Particle Velocity at 0.25 Time with 0.05mL Concentration:

Figure 4.35(c) Scaled particle velocity in reconstructed brain at 0.25 time with 0.05 mL
The Figure 4.35(c) shows the scaled particle velocity at 0.25 time when a dosage of
0.05mL is inserted into the blood stream. The value obtained at this time step is 1.0021m/sec at
the artery and 4.46E-10 at the target area, which is the least velocity observed through the cycle.
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Here only a few particles are observed in the tissue regions and concentrated particle at the tumor
region.
Particle Velocity at 0.5 Time with 0.05 mL Concentration:
The Figure 4.35(d) shows the particle velocity as 0.05 time. Here the particle flows
with a maximum velocity of only 4.5230m/sec. The scaled magnitudes shows the better view
of changes in particle velocity. In this time the particle velocity is least and it reaches the
value of 1.9E-8m/sec, due to rise observed at the point of the cycle.

Figure 4.35(d) Scaled Particle velocity in reconstructed brain at 0.25 time with 0.05 mL
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Figure 4.36 velocity distribution at the tumor region with changed concentrations
The Figure 4.36 shows the velocity penetrations of the drug with different concentrations
in the realistic brain at the site of tumor. A line plot passing through the tumor from the input as
artery is considered to see the results. As shown in the plot for the three different dosage inputs,
the velocity of 0.01 mL is far highest when compared to the other two dosages. If the values are
scaled on percentage, the 0.01mL velocities are 10% higher at the peak velocity of cardiac cycle
and 5% cycle at the negative phase of cardiac cycle and then the percentage reduced to 2%. But
the other two drug dosages gave almost nearer penetration velocity at every time step with less
reach of drug to areas out of target. Also the results of drug flow show much delivery of drug at
0.03mL when compared to 0.05mL, where the particles also carried away to other parts in more
quantity compared to 0.03mL case. With this we can say that 0.03mL could be the optimal drug
dosage for this case as there is no big change observed in the penetration velocity for the two
dosages. However, only velocity penetration could not definitely act as the deciding factor.
Therefore concentration of particles at the site of tumor is to be analyzed.
4.7 Results for Drug Concentration Distribution in Realistic Brain and at the Site of Tumor
The concentrations at times 0.25 and 0.5 are observed to analyze the concentration at the
target region. Since the two types of flows considered here are liquids, concentrations are shown
as the volume fractions. Also the results are scaled and magnified such that the highest volume
that can be shown in the figure is 55000, as it shows clearly the fate of concentrations of particles
at that the tumor area. At this time we can observe that with the increase in dosage the concentration
at the tumor site and the healthy regions is increasing. However we can see the lowest
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concentrations at the site of healthy regions in each case. But if tumor targeting is considered,
which is the main objective of this study, keeping in mind that healthy tissue should not be targeted
more, 0.03 mL dosage does a good job in delivering the target with adequate dosage. Even though
the highest dosage 0.05 mL is showing higher concentrations than the 0.03 mL, it also shows
highest concentration of 1.478 at the non-tumor region, which is 50% more than the value 0.5057
shown at non-tumor sites for 0.03mL distribution. Also the difference observed in the
concentration changes at the tumor site for both the concentration 0.03(b) and 0.05 (c) are very

small in numerical value, which prompts us to choose 0.03mL as the safe value that can be
administered to treat the target area.

Figure 4.37 Variation in drug concentration at tumor site with different input dosages
In order to find the optimal dosage other than the concentration distribution details we
also need to know the effect of particle size and particle type of the drug. For that study a line
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probe is drawn at the site of tumor crossing from artery to tumor from left to right and the effects
of penetration velocity changes are observed on plots by changing the parameters. The plots
shown below explain the differences in penetration velocity with respect to size and particle
type.
The plot in Figure 4.38 shows the velocity of drug Carmustine, which has the density
1460kg/m^3 at different time steps with change in particle diameter. Two particle diameters
are analyzed for the penetration velocity and the plot shows the lowest particle size of the drug
penetrates with more velocity when compared to highest diameter size. This shows that the
lowest diameter 0.5 microns can get into the pores of the tumor effectively when compared to
the other size 5 microns.
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Figure 4.38 Penetration velocity with change in diameter

Figure 4.39 Penetration velocity with change in density
This plot in Figure 4.39 show the penetration velocity with change in particle type. Two
drugs Temozolomide and Carmustine, which are commonly used as anti-cancer drugs, are used
here. The plot shows the velocity penetrations with change in density considering the effects of
gravity. It is seen that the lowest density drug can penetrate better into the target region when
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compared to high-density drug. However in order to justify these the diameter of the particle
has to be associated. The Figure 4.40 shows the variation with density of the drugs with two
different diameters.

Figure 4.40 Penetration velocity with change in particle size and type
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It shows that for change in diameter, two different drugs have shown increase in velocity
with a decrease in diameter. However if density is taken into account, the low-density drug with
lesser diameter has shown more penetrating effect than the high-density drug.
Finally the concentrations are plotted with respect to changed particle type at the site of
tumor. From the plot in Figure 4.41 we can observe that the concentrations are higher for the highdensity drug only at the highest peak velocity, whereas the rest of the plot shows almost equal
concentration, which prompts the result that low-density drug can surround the target more when
compared to high.

Figure 4.41 Concentration variation with change in particle size and type

5. CONCLUSION
A computational simulation model has been developed for analyzing the blood flow and
drug concentration distribution in cerebral regions including the artery-capillary network. The
computational analysis is done by solving governing equations of blood flow dynamics based on
Navier-Stokes equations and mass species transport based on Lagrangian particle flow equations.
The diffusion considered in the capillary-tissue regions is based on Brinkman’s model.
Analysis of blood flow is performed using experimentally derived cardiac input as inflow
and considering the blood as non-Newtonian in nature, which is closer to reality. The drug
concentration distribution is also observed around the tumor which is originated in the cerebral
regions, assigning it with anisotropic porosity. The drug distribution is done through intra-venal
administration with the administered drug parameters varying as 0.03mL to 0.05mL in dosage,
1460kg/m^3and 1960 kg/m^3 in drug density and 0.5 to 0.05 microns in particle size. The
simulation analysis results show that the increase in dosage has little effect on the target after a
certain amount of dosage. It also explains that the decrement in particle diameter and density as a
combination could prompt us with better penetration effect of the drug to the tumor.
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